We serve Chemical Name:(3R,7aS)-7a-methyl-3-propan-2-yl-2,3,6,7-tetrahydropyrrolo[2,1-b][1,3]oxazol-5-one CAS:123808-97-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(3R,7aS)-7a-methyl-3-propan-2-yl-2,3,6,7-tetrahydropyrrolo[2,1-b][1,3]oxazol-5-one](https://a.dearchem.com/CAS2/123808-97-9.png)
Chemical Name:(3R,7aS)-7a-methyl-3-propan-2-yl-2,3,6,7-tetrahydropyrrolo[2,1-b][1,3]oxazol-5-one
CAS.NO:123808-97-9
Synonyms:InChI=1/C10H17NO2/c1-7(2)8-6-13-10(3)5-4-9(12)11(8)10/h7-8H,4-6H2,1-3H3/t8-,10-/m0/s;(3R-CIS)-(-)-3-ISOPROPYL-7A-METHYLTETRAHYDROPYRROLO[2,1-B]OXAZOL-5(6H)-ONE;(3R-cis)-(-)-3-Isopropyl-7a-methyltetrahydropyrrolo-[2,1-b]oxazol-5(6H)-one;(3R,7aS)-7a-methyl-3-propan-2-yl-2,3,6,7-tetrahydropyrrolo[2,1-b]oxazol-5-one
Molecular Formula:C10H17NO2
Molecular Weight:183.24700
HS Code:
Physical and Chemical Properties:
Melting point:59-60ºC
Boiling point:82ºC (0.7 mmHg)
Density:1.09g/cm3
Index of Refraction:1.472-1.474
PSA:29.54000
Exact Mass:183.12600
LogP:1.31770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like InChI=1/C10H17NO2/c1-7(2)8-6-13-10(3)5-4-9(12)11(8)10/h7-8H,4-6H2,1-3H3/t8-,10-/m0/s chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3R,7aS)-7a-methyl-3-propan-2-yl-2,3,6,7-tetrahydropyrrolo[2,1-b]oxazol-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,InChI=1/C10H17NO2/c1-7(2)8-6-13-10(3)5-4-9(12)11(8)10/h7-8H,4-6H2,1-3H3/t8-,10-/m0/s Use and application,InChI=1/C10H17NO2/c1-7(2)8-6-13-10(3)5-4-9(12)11(8)10/h7-8H,4-6H2,1-3H3/t8-,10-/m0/s technical grade,usp/ep/jp grade.
Related News: After examining all the evidence, it was clear that more plausible explanations for the AML cases included the conditioning treatment the patients received to clear out bone marrow cells and the higher risk of blood cancer in people with sickle cell disease. 7-methylsulfanyl-10H-phenothiazine-2-carboxylic acid manufacturers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 6-{4-[(2-Thiophen-2-yl-ethylamino)-methyl]-phenyl}-pyridin-2-ylamine suppliers J&J’s top brass told the group that its shot holds up against the Delta variant compared with older versions of the virus. After 8 months, the vaccine presents a similar antibody and T-cell response to Delta as it does with other concerning variants, J&J reported. 2-{2-[2-(2-{2-[2-(2-Benzylsulfanyl-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethyl}-isoindole-1,3-dione vendor & factory After examining all the evidence, it was clear that more plausible explanations for the AML cases included the conditioning treatment the patients received to clear out bone marrow cells and the higher risk of blood cancer in people with sickle cell disease.,Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue.
